NCT05704985 2025-05-29
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Phase 1 Active not recruiting
DEKA Biosciences
Massachusetts General Hospital
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
VA Office of Research and Development
Massachusetts Eye and Ear Infirmary
Ascend Biopharmaceuticals Ltd